← Open Payments lookup

PHUONG NGUYEN: Open Payments

NPI 1518387703 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,252 in 62 payments from 10 companies in 2025. Trend: 2023 $1,065 · 2024 $1,810 · 2025 $1,252

Food & beverage: $1,167Education: $85
CompanyPaymentsAmount
Janssen Biotech, Inc.14$337
Madrigal Pharmaceuticals9$206
ABBVIE INC.11$201
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$170
Intercept Pharmaceuticals, Inc.8$138
Ipsen Biopharmaceuticals, Inc3$74
Takeda Pharmaceuticals U.S.A., Inc.2$49
Mirum Pharmaceuticals, Inc.1$34
Napo Pharmaceuticals Inc1$25
PFIZER INC.1$19

Products named: TREMFYA, REZDIFFRA, XIFAXAN, OCALIVA, SKYRIZI, IQIRVO, MAVYRET, RINVOQ.

Industry payments across TX — which companies pay providers there.